{
  "questions": [
    {
      "type": "factoid",
      "id": "56cf36263975bb303a000007",
      "exact_answer": [
        [
          ".",
          0.9471401187506308
        ],
        [
          "chondrosarcoma",
          0.903436443968375
        ],
        [
          "Scleraxis",
          0.8779679309828358
        ],
        [
          "Emx2",
          0.548870278896933
        ],
        [
          "Cart1",
          0.5185867892659292
        ],
        [
          "acrania and meroanencephaly",
          0.41042435411504447
        ],
        [
          "acrania",
          0.32900254796751166
        ],
        [
          "craniofacial development is strongly associated with beak shape diversity",
          0.20119683552663276
        ],
        [
          "autosomal-recessive ALX-related frontonasal dysplasia",
          0.19472207261526528
        ],
        [
          "meroanencephaly",
          0.1833837383704209
        ],
        [
          "Cart1 and Carm1 - result in neural tube defects in mice.",
          0.17706326353509252
        ],
        [
          "autosomal-recessive ALX-related frontonasal dysplasia.",
          0.17180985646665967
        ],
        [
          "beak shape diversity",
          0.1596958974430178
        ],
        [
          "Potocki-Shaffer syndrome (PSS",
          0.1561865664848804
        ],
        [
          "Potocki-Shaffer syndrome",
          0.127582924059689
        ],
        [
          "ALX-related frontonasal dysplasia. We present an autosomal-recessive frontonasal dysplasia",
          0.12390971854359376
        ],
        [
          "Potocki-Shaffer syndrome (PSS)",
          0.10691334851876512
        ],
        [
          "craniosynostosis in addition, and more recently the aristaless-like homeobox genes ALX3,",
          0.10275536571606037
        ],
        [
          "ALX-related frontonasal dysplasia",
          0.09803326413153368
        ],
        [
          "ALX-related frontonasal dysplasia.",
          0.08649805752979912
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c1f010ef6e394741000041",
      "exact_answer": [
        [
          "meningioma",
          0.6145456659771289
        ],
        [
          "olfactory groove meningiomas",
          0.549572143802283
        ],
        [
          "atypical meningioma",
          0.5263682942304992
        ],
        [
          "Meningiomas",
          0.4656559390748115
        ],
        [
          "Spinal Atypical (World Health Organization Grade II) Meningiomas",
          0.4242531666803521
        ],
        [
          "meningiomas. BACKGROUND: The relevance of the Simpson grading system as a predictor of meningioma",
          0.38113222703461025
        ],
        [
          "Simpson grade I-II (P = 0.0096),",
          0.261519969631686
        ],
        [
          "Spinal Atypical",
          0.20206746270261045
        ],
        [
          "atypical meningiomas",
          0.11617358188636959
        ],
        [
          "atypical meningiomas.",
          0.044253211336681544
        ],
        [
          "olfactory groove",
          0.02660697281618363
        ],
        [
          "Simpson Grade I-III Resection of Spinal Atypical (World Health Organization Grade II) Meningiomas",
          0.02294454760319676
        ],
        [
          ", Simpson grade I-II (P = 0.0096),",
          0.02134920244540131
        ],
        [
          "Atypical (World Health Organization Grade II) Meningiomas",
          0.020855899209020742
        ],
        [
          ".",
          0.020491930934747046
        ],
        [
          "Simpson I-II",
          0.01818523603954173
        ],
        [
          "Simpson grade I-II",
          0.017276042899255103
        ],
        [
          "Atypical",
          0.015808745032052842
        ],
        [
          "(P = 0.0096),",
          0.015111394527621318
        ],
        [
          "I-II (P = 0.0096),",
          0.013685404190176111
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c3184050c68dd416000003",
      "exact_answer": [
        [
          "antihypertensive",
          1.491856652319113
        ],
        [
          "antihypertensive drug in blacks with essential hypertension",
          0.7925539719219785
        ],
        [
          "antihypertensive treatment",
          0.24692224111052097
        ],
        [
          "antihypertensive therapy.",
          0.13022655564800337
        ],
        [
          "antihypertensive therapy",
          0.11289289257539847
        ],
        [
          "antihypertensive drug in blacks with essential hypertension,",
          0.05392301197762448
        ],
        [
          "antihypertensive drug",
          0.016301161197337693
        ],
        [
          "Isradipine monotherapy was an effective antihypertensive drug in blacks with essential hypertension",
          0.014831693150502928
        ],
        [
          "Regression of left ventricular hypertrophy with isradipine antihypertensive",
          0.014170152404933316
        ],
        [
          "antihypertensive treatment with isradipine as monotherapy",
          0.01312951587113619
        ],
        [
          "left ventricular hypertrophy with isradipine antihypertensive",
          0.012602413210714139
        ],
        [
          "antihypertensive therapy. To assess left ventricular (LV) structural and functional changes",
          0.00839331741415278
        ],
        [
          "essential hypertension",
          0.007559495827906964
        ],
        [
          "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily",
          0.006775663718332257
        ],
        [
          "hypertension",
          0.0057427542846777225
        ],
        [
          "hypertensive patients with either hyperlipidemia or NIDDM.",
          0.005066321527187704
        ],
        [
          "antihypertens",
          0.00449768791750714
        ],
        [
          "Regression of left ventricular hypertrophy",
          0.00424659341955455
        ],
        [
          "monotherapy was an effective antihypertensive drug in blacks with essential hypertension",
          0.004182668304810139
        ],
        [
          "hypertensive",
          0.004109282121993894
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56cf3f4f3975bb303a000008",
      "exact_answer": [
        [
          "Xp21-p11",
          0.9990466742603069
        ],
        [
          "(Xp21-p11",
          0.000798095121642261
        ],
        [
          "Xp21",
          6.188261677409722e-05
        ],
        [
          "MAOA): chromosome position (Xp21-p11",
          3.582931900422802e-05
        ],
        [
          "Xp21-p11)",
          2.1252210575436e-05
        ],
        [
          "chromosome position (Xp21-p11",
          1.5768454612066656e-05
        ],
        [
          "monoamine oxidase gene (MAOA): chromosome position (Xp21-p11",
          6.735706616468894e-06
        ],
        [
          "X",
          4.723962725793186e-06
        ],
        [
          "11",
          3.676987942460484e-06
        ],
        [
          "Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11",
          1.798772520785869e-06
        ],
        [
          "Xp21-p",
          1.03946137132487e-06
        ],
        [
          "p11",
          8.749340806623742e-07
        ],
        [
          "(MAOA): chromosome position (Xp21-p11",
          8.711258371967414e-07
        ],
        [
          "Xp21-p11) and DNA polymorphism. An essentially full-length cDNA",
          7.028529751779649e-07
        ],
        [
          "(Xp21",
          4.943534254636454e-08
        ],
        [
          "(Xp21-p11)",
          1.6977470644129472e-08
        ],
        [
          "(X",
          3.773769237625311e-09
        ],
        [
          "MAOA): chromosome position (Xp21",
          2.219327759493462e-09
        ],
        [
          "chromosome position (Xp21",
          9.767243703611174e-10
        ],
        [
          "(Xp21-p",
          8.30380672859134e-10
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56b76f496e3f8eaf4c000002",
      "exact_answer": [
        [
          "Spt-Ada-Gcn5-acetyltransferase",
          2.99001409086944
        ],
        [
          "Spt-Ada-Gcn5 acetyltransferase",
          2.972432215876987
        ],
        [
          "Spt-Ada-Gcn5 acetyltransferase)",
          0.014939972454025771
        ],
        [
          "(Spt-Ada-Gcn5 Acetyltransferase",
          0.006319825709350935
        ],
        [
          "Spt-Ada-Gcn5",
          0.006220400160855208
        ],
        [
          "(Spt-Ada-Gcn5-acetyltransferase",
          0.0032883802553221163
        ],
        [
          "Spt20, a structural subunit of the Spt-Ada-Gcn5-acetyltransferase",
          0.0015252782645498598
        ],
        [
          "The molecular organization of the yeast transcriptional coactivator Spt-Ada-Gcn5 acetyltransferase",
          0.0010209924124911787
        ],
        [
          "Spt-Ada",
          0.0006481384069183072
        ],
        [
          "Spt-Ada-Gcn5-acetyltransferase)",
          0.0005802142581134014
        ],
        [
          "SAGA (Spt-Ada-Gcn5 acetyltransferase",
          0.0005678646894946093
        ],
        [
          "Spt",
          0.0004947310284916327
        ],
        [
          "SAGA (Spt-Ada-Gcn5-acetyltransferase",
          0.00045413933544089587
        ],
        [
          "Spt-Ada-Gcn5-acetyltransferase (SAGA",
          0.00042042905853152186
        ],
        [
          "Spt-Ada-Gcn5-acetyltransferase (SAGA)",
          0.00028131396155552796
        ],
        [
          "yeast transcriptional coactivator Spt-Ada-Gcn5 acetyltransferase",
          0.00012487673414042554
        ],
        [
          "Spt-Ada-Gcn5-acetyltransferase (SAGA) transcriptional activation complex,",
          0.00010582568395849106
        ],
        [
          "Spt-Ada-Gcn5 acetyltransferase (SAGA)",
          8.050198269415463e-05
        ],
        [
          "Spt-Ada-Gcn5 Ace",
          6.90176365208171e-05
        ],
        [
          "Spt-Ada-Gcn5 acetyltransferase (SAGA",
          4.686661217104563e-05
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56d19a363975bb303a000017",
      "exact_answer": [
        [
          "MTBP",
          0.9996028645562569
        ],
        [
          "MDM two binding protein (MTBP",
          0.000159757957567173
        ],
        [
          "MTBP)",
          0.00014698537880018965
        ],
        [
          "(MTBP",
          5.594767292852485e-05
        ],
        [
          "MTBP) as a factor that interacts with Treslin/TICRR throughout the cell cycle.",
          2.5309459068334983e-05
        ],
        [
          "cyclin-dependent kinases and the DNA damage checkpoint. We identified MDM two binding protein (MTBP",
          2.878433566866351e-06
        ],
        [
          "MTBP) as a factor that interacts with Treslin/TICRR",
          2.1609030398377e-06
        ],
        [
          "P",
          2.116456064855246e-06
        ],
        [
          "We identified MDM two binding protein (MTBP",
          1.9123773940061313e-06
        ],
        [
          "MDM two binding protein (MTBP)",
          2.3491413182153794e-08
        ],
        [
          "MDM two binding protein",
          2.1304890067364877e-08
        ],
        [
          "(MTBP)",
          8.226757035194078e-09
        ],
        [
          "TopBP1",
          3.888342230580538e-09
        ],
        [
          "Treslin/TICRR (TopBP1-interacting, replication stimulating protein/TopBP1",
          2.1965801070544865e-09
        ],
        [
          "TopBP1-interacting, checkpoint, and replication regulator), the human ortholog of the yeast Sld3",
          2.0416228964403986e-09
        ],
        [
          "(MTBP) as a factor that interacts with Treslin/TICRR throughout the cell cycle.",
          1.4165679072775416e-09
        ],
        [
          "Treslin/TICRR (TopBP1",
          1.3001928836994355e-09
        ],
        [
          "TopBP1-interacting, replication stimulating protein/TopBP1",
          1.2585737043532587e-09
        ],
        [
          "MTBP is required for DNA replication irrespective of a cell's p53 status. We propose that MTBP",
          8.61487740377249e-10
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c58ceeb04e159d0e000004",
      "exact_answer": [
        [
          "form a covalently closed continuous loop",
          0.740552595586362
        ],
        [
          "biogenesis",
          0.7321082904413838
        ],
        [
          "stable molecules",
          0.6881362893770593
        ],
        [
          "regulation of post transcriptional gene expression",
          0.5253322840791327
        ],
        [
          "Circular RNA may be an ancient, conserved feature of eukaryotic gene expression programs.",
          0.2554824428263055
        ],
        [
          "Circular RNA may be an ancient, conserved feature of eukaryotic gene expression programs",
          0.20690653143538099
        ],
        [
          "Circular RNAs are new players in regulation of post transcriptional gene expression",
          0.1235091736375464
        ],
        [
          "stable",
          0.11557141444646224
        ],
        [
          "regulation of post transcriptional gene expression.",
          0.10297820491855708
        ],
        [
          "stable molecules, localized in the cytoplasmic component of the cells.",
          0.09289679824560153
        ],
        [
          "conserved feature of eukaryotic gene expression programs.",
          0.08393090615777846
        ],
        [
          "conserved feature of eukaryotic gene expression programs",
          0.06797278310486839
        ],
        [
          "circRNAs) are a novel type of RNA that, unlike linear RNAs, form a covalently closed continuous loop",
          0.06598636004484595
        ],
        [
          "post transcriptional gene expression",
          0.06364838857636541
        ],
        [
          "ancient, conserved feature of eukaryotic gene expression programs.",
          0.0570762233187325
        ],
        [
          "Circular RNA is expressed across the eukaryotic tree of life.",
          0.053339660116594106
        ],
        [
          "may be an ancient, conserved feature of eukaryotic gene expression programs.",
          0.04710706545366682
        ],
        [
          "ancient, conserved feature of eukaryotic gene expression programs",
          0.04622408985786558
        ],
        [
          "new players in regulation of post transcriptional gene expression",
          0.04568425876306827
        ],
        [
          "may be an ancient, conserved feature of eukaryotic gene expression programs",
          0.03815040834623685
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56b76d916e3f8eaf4c000001",
      "exact_answer": [
        [
          "Flaviviridae",
          0.9982378386560565
        ],
        [
          "Flaviviridae)",
          0.000876970309500808
        ],
        [
          "Zika virus (ZIKV; genus Flavivirus, family Flaviviridae",
          0.00044222302735244496
        ],
        [
          "family Flaviviridae",
          0.00020057182417425418
        ],
        [
          "Flavivirus, family Flaviviridae",
          0.0001692950161420945
        ],
        [
          "genus Flavivirus, family Flaviviridae",
          2.9811259814905e-05
        ],
        [
          "Flav",
          1.0724356883495901e-05
        ],
        [
          "(ZIKV; genus Flavivirus, family Flaviviridae",
          8.64589684205546e-06
        ],
        [
          "Flaviviri",
          7.1135826449907805e-06
        ],
        [
          "BACKGROUND: Zika virus (ZIKV; genus Flavivirus, family Flaviviridae",
          3.862294854740699e-06
        ],
        [
          "F",
          3.641865744113509e-06
        ],
        [
          "Flaviv",
          2.741109274278021e-06
        ],
        [
          "Flaviviridae) is",
          1.439765037158712e-06
        ],
        [
          "; genus Flavivirus, family Flaviviridae",
          1.2783383057555935e-06
        ],
        [
          "dae",
          1.0881051186320106e-06
        ],
        [
          "virus (ZIKV; genus Flavivirus, family Flaviviridae",
          8.661717396289458e-07
        ],
        [
          ": Zika virus (ZIKV; genus Flavivirus, family Flaviviridae",
          7.607975440155469e-07
        ],
        [
          "ZIKV; genus Flavivirus, family Flaviviridae",
          5.629158651504615e-07
        ],
        [
          "Zika virus (ZIKV; genus Flavivirus, family Flaviviridae)",
          3.8850106672752604e-07
        ],
        [
          "family Flaviviridae)",
          1.7620603819230926e-07
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c8274f5795f9a73e00000d",
      "exact_answer": [
        [
          "motoneuronal",
          0.9998728521567547
        ],
        [
          "microglia",
          0.9987213770111926
        ],
        [
          "embryonic stem cells",
          0.8431387399913852
        ],
        [
          "motor neurons",
          0.8259144654624248
        ],
        [
          "muscle",
          0.18699302789877137
        ],
        [
          "neurodegenerative disease characterized by ascending muscle",
          0.13095746089927449
        ],
        [
          "skeletal muscle satellite cells",
          0.10970089450723222
        ],
        [
          "motor neurons.",
          0.09217888081730442
        ],
        [
          "skeletal muscle",
          0.06311151378906393
        ],
        [
          "muscle weakness, atrophy and paralysis.",
          0.05706962335330785
        ],
        [
          "myofiber-associated skeletal muscle satellite cells",
          0.05185538105111734
        ],
        [
          "embryonic stem",
          0.05131279660850691
        ],
        [
          "embryonic stem cells overexpressing mutant superoxide dismutase 1.",
          0.0509405780880731
        ],
        [
          "neurodegenerative disease characterized by ascending muscle weakness, atrophy and paralysis.",
          0.03996776271719081
        ],
        [
          "motor neurons. In the ALS motor neurons",
          0.03769420400189989
        ],
        [
          "skeletal muscle satellite cells (SMSCs",
          0.03165191768971547
        ],
        [
          "myofiber-associated skeletal muscle",
          0.02983267922240141
        ],
        [
          "skeletal muscle satellite",
          0.02964916311615223
        ],
        [
          "skeletal muscle satellite cells (SMSCs)",
          0.027133325406389325
        ],
        [
          "ALS) is the most common adult-onset neurodegenerative disease characterized by ascending muscle",
          0.026290059099292273
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56b397a98525abca1e000003",
      "exact_answer": [
        [
          "energy reserve",
          0.9662826967053356
        ],
        [
          "growth and fission",
          0.835173060773276
        ],
        [
          "adipocytes",
          0.7598003860598438
        ],
        [
          "contribute to diverse cellular functions",
          0.7100777174812299
        ],
        [
          "regulating storage and mobilization of lipids in response to metabolic demands",
          0.3158946349606405
        ],
        [
          "clustering and growth",
          0.27235215305274757
        ],
        [
          "regulating storage and mobilization",
          0.27141615550064513
        ],
        [
          "regulating storage and mobilization of lipids",
          0.2555834324274022
        ],
        [
          "clustering and growth,",
          0.20920652699826506
        ],
        [
          "adipocytes.",
          0.12610985314325635
        ],
        [
          "clustering and growth, and is enriched at lipid droplet junctions.",
          0.10200271351482097
        ],
        [
          "clustering",
          0.08799348234114715
        ],
        [
          "growth",
          0.08575011103502082
        ],
        [
          "contribute to diverse cellular functions.",
          0.07295917628581942
        ],
        [
          "clustering and growth, and is enriched at lipid droplet junctions",
          0.053009816652013514
        ],
        [
          "growth,",
          0.028670482614430656
        ],
        [
          "promotes lipid droplet clustering and growth",
          0.02597987356625587
        ],
        [
          "regulating storage and mobilization of lipids in response to metabolic demands.",
          0.02429256720771385
        ],
        [
          "promotes lipid droplet clustering and growth,",
          0.019956365535314022
        ],
        [
          "growth and fission in adipocyte cells.",
          0.019709563180723925
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56cae3eb5795f9a73e000021",
      "exact_answer": [
        [
          "pediatric",
          0.9914892689827737
        ],
        [
          "15 to 25 years",
          0.9536648511385664
        ],
        [
          "Fifteen percent of incident Crohn's disease (CD) cases are diagnosed at older ages",
          0.7454776755890946
        ],
        [
          "20",
          0.7425706104225629
        ],
        [
          "40 years and older",
          0.6147903667838607
        ],
        [
          "54.9 \u00b1 15.4 years,",
          0.408402800845335
        ],
        [
          "10-19",
          0.3916687142670075
        ],
        [
          "10-19-year-old",
          0.2556313422823244
        ],
        [
          "54.9 \u00b1 15.4 years",
          0.24197705529295852
        ],
        [
          "<17,",
          0.16939664942677232
        ],
        [
          "<17, 17-40, 41-59",
          0.15477511601218
        ],
        [
          "elderly",
          0.14287939774454705
        ],
        [
          "<17",
          0.13829651880726512
        ],
        [
          "(20",
          0.13336389556259454
        ],
        [
          "10-19-year-old age group.",
          0.1274276840799514
        ],
        [
          "(Montreal Classification: P = 0.0006",
          0.10128000364020412
        ],
        [
          "(Montreal Classification: P = 0.0006) with patients diagnosed <17 years (n = 13",
          0.09538244388776598
        ],
        [
          "(Montreal Classification: P = 0.0006) with patients diagnosed <17 years",
          0.08762643558546256
        ],
        [
          "older ages",
          0.08369825067160808
        ],
        [
          "58.1%) in the 40 years and older",
          0.0814092910951546
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c85ed65795f9a73e000012",
      "exact_answer": [
        [
          "inhibition",
          1.0052480828854993
        ],
        [
          "inhibits",
          0.5212858895463969
        ],
        [
          "inhibit",
          0.24599231780056163
        ],
        [
          "inhibited",
          0.2376577814166359
        ],
        [
          "inhibits T-cell activation and proliferation.",
          0.14981236415302157
        ],
        [
          "inhibited T-cell activation",
          0.133721815028792
        ],
        [
          "dasatinib and staurosporine inhibited",
          0.09458951408282537
        ],
        [
          "inhibition of antigen-specific T-cell proliferation",
          0.09243795256969681
        ],
        [
          "inhibits T-cell activation",
          0.08832817333965014
        ],
        [
          "dasatinib",
          0.058395051489013805
        ],
        [
          "dasatinib and staurosporine inhibited T-cell activation",
          0.05566690032489286
        ],
        [
          "inhibits T-cell activation and proliferation",
          0.054398145815063526
        ],
        [
          "dasatinib and staurosporine inhibit",
          0.039325915460057224
        ],
        [
          "dasatinib-mediated inhibition",
          0.03778760856919102
        ],
        [
          "inhibited T-cell activation, proliferation",
          0.021113116403143766
        ],
        [
          "inhibition of antigen-specific T-cell effector functions",
          0.01889994368079294
        ],
        [
          "inhibited antigen-specific proliferation",
          0.014428295598897026
        ],
        [
          "inhibition of antigen-specific T-cell effector functions by dasatinib",
          0.01253008688214105
        ],
        [
          "inhibitory effects of dasatinib",
          0.011452335747277576
        ],
        [
          "inhibits T-cell activation and proliferation. Dasatinib",
          0.010606769629756808
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56bb68f9ac7ad1001900000b",
      "exact_answer": [
        [
          "phthirus pubis",
          1.678880798497488
        ],
        [
          "blepharoconjunctivitis",
          0.9989198685635658
        ],
        [
          "ectoparasitosis",
          0.9552287899235571
        ],
        [
          "chronic conjunctivitis",
          0.9358145966554922
        ],
        [
          "tick and louse",
          0.7087361265746148
        ],
        [
          "lice infestation of palpabrae",
          0.6485599471489462
        ],
        [
          "Phthirus pubis (pubic lice",
          0.1814280131743119
        ],
        [
          "the tick and louse",
          0.09967118606296806
        ],
        [
          "Phthirus pubis (pubic lice)",
          0.08230559895630107
        ],
        [
          "lice",
          0.06565418720335049
        ],
        [
          "conjunctivitis",
          0.05174934034526946
        ],
        [
          "tick",
          0.031016846089444966
        ],
        [
          "pubic lice",
          0.025734522384536353
        ],
        [
          "blepharoconjuctivitis",
          0.021865956789232033
        ],
        [
          "ectoparasitosis in which Phthirus pubis infest the eyelashes",
          0.020625669315286203
        ],
        [
          "lice infestation",
          0.020140157213837478
        ],
        [
          "tick and louse (Pthirus pubis)",
          0.017291051820940085
        ],
        [
          "blepharoconjuctivitis.",
          0.015672290584344432
        ],
        [
          ".",
          0.014007256117789097
        ],
        [
          "lice infestation of palpabrae)",
          0.012893723313069008
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56d3346cf22319765a000008",
      "exact_answer": [
        [
          "an autosomal recessive congenital defect",
          0.6921933537558754
        ],
        [
          "dextrocardia",
          0.5758747669345345
        ],
        [
          "SIT",
          0.5261808406963925
        ],
        [
          "congenital anomaly",
          0.3617543655420049
        ],
        [
          "Situs inversus totalis (SIT) is an uncommon congenital syndrome",
          0.30202938952967745
        ],
        [
          "a rare congenital anomaly",
          0.2746754083001153
        ],
        [
          "Situs inversus totalis (SIT",
          0.2737497369707973
        ],
        [
          "an uncommon congenital syndrome",
          0.2723363248873499
        ],
        [
          "autosomal recessive congenital defect",
          0.2674315606052461
        ],
        [
          "SIT) is an uncommon congenital syndrome",
          0.26424121346839347
        ],
        [
          "rare congenital anomaly",
          0.22617981043028176
        ],
        [
          "dextrocardia situs inversus totalis",
          0.22156500897225223
        ],
        [
          "Situs inversus totalis",
          0.19147181860154674
        ],
        [
          "SIT) represents a total vertical transposition of the thoracic and abdominal organs",
          0.1632222138177782
        ],
        [
          "neurally mediated syncope (NMS) of the cardioinhibitory type. The patient had dextrocardia",
          0.12925590226187023
        ],
        [
          "SIT)",
          0.0951786760775877
        ],
        [
          "Situs inversus totalis (SIT)",
          0.07740138647461775
        ],
        [
          "totalis",
          0.058196762112059715
        ],
        [
          "Situs inversus totalis is a rare congenital anomaly",
          0.05612904486801038
        ],
        [
          "totalis (SIT",
          0.05196907024697794
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c83f365795f9a73e000011",
      "exact_answer": [
        [
          "prion domain",
          1.4394596800227681
        ],
        [
          "prion-like domain",
          1.117714917602041
        ],
        [
          "prion-like domains",
          0.8901628012308639
        ],
        [
          "PrLDs",
          0.42924410866558643
        ],
        [
          "prion domain. Indeed, of 210 human RRM-bearing proteins, 29 have a putative prion domain",
          0.2646187316947133
        ],
        [
          "prion-like",
          0.12019309563292588
        ],
        [
          "prion-like domain (PrLD",
          0.10268283683484973
        ],
        [
          "PrLD",
          0.08052876864475451
        ],
        [
          "the PrLDs",
          0.07075816355032265
        ],
        [
          "prion domain,",
          0.07052094565191887
        ],
        [
          "N-terminal prion-like domain",
          0.06915814489176524
        ],
        [
          "prion domain. Indeed, of 210 human RRM-bearing proteins, 29 have a putative prion domain,",
          0.03937032079111795
        ],
        [
          "FUS N-terminal prion-like domain",
          0.0368818537190456
        ],
        [
          "prion-like domain (PrLD)",
          0.03678755906902395
        ],
        [
          "'prion domain",
          0.030712376269825717
        ],
        [
          "prion domain.",
          0.027381098898529858
        ],
        [
          "prion domain, and 12 of these are in the top 60 prion",
          0.0257230995240928
        ],
        [
          "prion domains",
          0.020167497525848385
        ],
        [
          "prion",
          0.018296393923482805
        ],
        [
          "PrLD)",
          0.018223207398251274
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "569e7721ceceede94d000001",
      "exact_answer": [
        [
          "to better understand the transcriptional network that regulates macrophage differentiation",
          0.1735496303298742
        ],
        [
          "to uncover novel components of the transcriptome",
          0.0069187547252841115
        ],
        [
          "better understand the transcriptional network that regulates macrophage differentiation",
          0.005959874523106054
        ],
        [
          "uncover novel components of the transcriptome",
          0.002616357076702375
        ],
        [
          "set out to better understand the transcriptional network that regulates macrophage differentiation",
          0.00010122841811589176
        ],
        [
          "to better understand the transcriptional network",
          6.98510392306304e-05
        ],
        [
          "to uncover novel components of the transcriptome employing a series of high-throughput experiments.",
          1.875228838516196e-05
        ],
        [
          "to better understand",
          1.7320882744255324e-05
        ],
        [
          "to",
          9.562695216499646e-06
        ],
        [
          "uncover novel components of the transcriptome employing a series of high-throughput experiments.",
          7.091259102102009e-06
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c1f00cef6e39474100003e",
      "exact_answer": [
        [
          "peroxisome proliferator-activated",
          1.0278623909886822
        ],
        [
          "peroxisome proliferator-activated receptors",
          0.8102693595814497
        ],
        [
          "peroxisome proliferator-activated receptor-\u03b1/\u03b3",
          0.7799779507110636
        ],
        [
          "dual peroxisome proliferator-activated receptor \u03b1/\u03b3",
          0.5596166542314075
        ],
        [
          "peroxisome proliferator-activated receptor \u03b1/\u03b3",
          0.41959943662935467
        ],
        [
          "dual peroxisome proliferator-activated receptor-\u03b1/\u03b3",
          0.13714074935276216
        ],
        [
          "peroxisome proliferator-activated receptors \u03b1 and \u03b3;",
          0.0804642623613446
        ],
        [
          "\u03b1/\u03b3",
          0.07839480958995328
        ],
        [
          "peroxisome proliferator-activated receptors \u03b1 and \u03b3",
          0.04308034570607531
        ],
        [
          "peroxisome proliferator-activated receptors \u03b1",
          0.025245419108259906
        ],
        [
          "peroxisome proliferator-activated receptor",
          0.004579113856195814
        ],
        [
          "proliferator-activated receptor-\u03b1/\u03b3",
          0.0033126482974531195
        ],
        [
          "peroxisome proliferator",
          0.0027758414104796076
        ],
        [
          "Aleglitazar acts through balanced activation of peroxisome proliferator-activated",
          0.0027504971623611577
        ],
        [
          "Aleglitazar is a dual peroxisome proliferator-activated receptor \u03b1/\u03b3",
          0.0025532457314001796
        ],
        [
          "peroxisome proliferator-activated receptors \u03b1 and \u03b3; warfarin",
          0.002404600022441568
        ],
        [
          "balanced peroxisome proliferator-activated receptor-\u03b1/\u03b3",
          0.00218918610155229
        ],
        [
          "Aleglitazar is a dual agonist of peroxisome proliferator-activated receptors",
          0.00199272749497545
        ],
        [
          "peroxisome proliferator-activated receptor-\u03b1/\u03b3 agonist aleglitazar",
          0.0018612563484735156
        ],
        [
          "peroxisome proliferator-activated receptor-\u03b1/\u03b3 agonist",
          0.0016676061415437304
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56a39d60496b62f23f000006",
      "exact_answer": [
        [
          "r3Cseq",
          0.9986381426581882
        ],
        [
          "r3Cseq:",
          0.0004761895036342068
        ],
        [
          "r3Cseq: an R/Bioconductor",
          0.00042214423172390076
        ],
        [
          "r3Cseq,",
          0.00015234644074142966
        ],
        [
          "r3Cseq: an R/Bioconductor package for the discovery of long-range genomic interactions",
          0.00011573979257948286
        ],
        [
          "r3",
          7.965702197035805e-05
        ],
        [
          "q",
          1.2394894988688084e-05
        ],
        [
          "Cseq",
          8.259520805954263e-06
        ],
        [
          "r3Cseq, an R/Bioconductor",
          6.780431522760492e-06
        ],
        [
          "r3Cseq, an R/Bioconductor package designed to perform 3C-seq",
          2.6808687672005375e-06
        ],
        [
          "3C-seq",
          1.6011700734801177e-06
        ],
        [
          "r3Cseq, an R/Bioconductor package designed to perform 3C-seq data analysis",
          1.1280147853880885e-06
        ],
        [
          "We present r3Cseq",
          4.908349641086991e-07
        ],
        [
          ".",
          1.0602223216127133e-07
        ],
        [
          "next-generation sequencing data.",
          9.994415709251114e-08
        ],
        [
          "We present r3Cseq,",
          8.748674612530979e-08
        ],
        [
          "3C",
          3.190908703138894e-08
        ],
        [
          "Cseq,",
          2.8498742920716055e-08
        ],
        [
          "q,",
          2.6387108400920564e-08
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56cafa845795f9a73e00002e",
      "exact_answer": [
        [
          "mTOR",
          0.9937510780848757
        ],
        [
          "mTORC1",
          0.0035384673687478317
        ],
        [
          "mTOR pathway",
          0.0026155958728912637
        ],
        [
          "The mTOR",
          6.428184789909755e-05
        ],
        [
          "mTORC1, in coordination with mTORC2",
          1.4326462926777545e-05
        ],
        [
          "mTOR pathway controls cell proliferation by regulating the FoxO3a",
          5.590822072790822e-06
        ],
        [
          "R",
          5.312730671586728e-06
        ],
        [
          "mTORC1, in coordination with mTORC2,",
          2.438698199918216e-06
        ],
        [
          "mTORC1, in coordination with mTORC2, controls cell proliferation by regulating FoxO3a",
          1.9772911198565165e-06
        ],
        [
          "mTORC",
          6.994039830082129e-07
        ],
        [
          "The mTOR pathway",
          1.6919260745933313e-07
        ],
        [
          "mTORC2",
          3.072814066675842e-08
        ],
        [
          "R pathway",
          1.3983337200664881e-08
        ],
        [
          "mTORC2,",
          5.230646371952257e-09
        ],
        [
          "mTORC2, controls cell proliferation by regulating FoxO3a",
          4.240996537709238e-09
        ],
        [
          "serum- and glucocorticoid-inducible kinase 1",
          2.924263994306742e-09
        ],
        [
          "mTORC1 inactivation induced downregulation of serum- and glucocorticoid-inducible kinase 1",
          2.348198917310917e-09
        ],
        [
          "glucocorticoid-inducible kinase 1",
          1.1841568206376626e-09
        ],
        [
          "mTORC1 and mTORC2, and plays a crucial role in controlling cell proliferation. To dissect mTOR",
          8.636002212351096e-10
        ],
        [
          "serum- and glucocorticoid-inducible kinase 1 (SGK1",
          7.206639664194159e-10
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c1f00def6e39474100003f",
      "exact_answer": [
        [
          "sPLA2",
          1.5075064977738002
        ],
        [
          "secretory phospholipase A2",
          0.40559034089574675
        ],
        [
          "sPLA(2)",
          0.24413525141752995
        ],
        [
          "(such as varespladib",
          0.23526152915871698
        ],
        [
          "varespladib",
          0.1858473378878198
        ],
        [
          "A-002",
          0.18521292989757918
        ],
        [
          "sPLA(2) inhibitor,",
          0.1846723309618489
        ],
        [
          "secretory phospholipase A2 (sPLA2",
          0.13867559697596948
        ],
        [
          "sPLA2 inhibitor for the treatment of coronary artery disease. Group X sPLA2",
          0.13297184989143235
        ],
        [
          "sPLA(2",
          0.1091545125439021
        ],
        [
          "(such as varespladib and darapladib",
          0.10454338266898962
        ],
        [
          "secretory phospholipase A2 (sPLA2)",
          0.104352217202542
        ],
        [
          "(such as varespladib and darapladib).",
          0.08388312659538179
        ],
        [
          "sPLA",
          0.08339090719670911
        ],
        [
          "varespladib, a reversible sPLA(2)",
          0.07005286470294267
        ],
        [
          "sPLA2)",
          0.06897068189668853
        ],
        [
          "varespladib and darapladib",
          0.06873729389389452
        ],
        [
          "sPLA(2) inhibitor, and darapladib, a selective Lp-PLA(2) inhibitor.",
          0.06452182480772935
        ],
        [
          "sPLA(2) inhibitor, and darapladib",
          0.06112595186039595
        ],
        [
          "(such as varespladib and darapladib)",
          0.05777044218107018
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56d1e23c67f0cb3d66000009",
      "exact_answer": [
        [
          "YAP",
          0.9284934836812712
        ],
        [
          "TAZ",
          0.7464193025935866
        ],
        [
          "Yap and Taz,",
          0.5211682476325248
        ],
        [
          "YAP and TAZ",
          0.5062352935511116
        ],
        [
          "(1) YAP and its paralog TAZ;",
          0.4249917904534919
        ],
        [
          "YAP and TAZ transcription coactivators. YAP",
          0.31432694940254924
        ],
        [
          "YAP)/TAZ",
          0.1806350978424118
        ],
        [
          "YAP-TEAD",
          0.13468853276166737
        ],
        [
          "(1) YAP and its paralog TAZ",
          0.11882035082513037
        ],
        [
          "Yap and Taz, which bind to and activate Teads.",
          0.11508403187396594
        ],
        [
          "TEAD",
          0.10767511591624498
        ],
        [
          "(1) YAP and its paralog TAZ; (2) Vgll proteins; and (3) p160s.",
          0.10375533846440942
        ],
        [
          "(1) YAP",
          0.08940643702211512
        ],
        [
          "Vgll1-TEAD and the YAP-TEAD",
          0.07954715923408953
        ],
        [
          "YAP and its paralog TAZ;",
          0.06109203680924524
        ],
        [
          "(1) YAP and its paralog TAZ; (2) Vgll proteins;",
          0.04233415776731072
        ],
        [
          "Taz,",
          0.03974311280888302
        ],
        [
          "(1) YAP and its paralog TAZ; (2) Vgll proteins",
          0.034154058224220914
        ],
        [
          "YAP and TAZ, despite having a varied primary sequence. Vgll1-TEAD",
          0.03401253608371787
        ],
        [
          "(1) YAP and its paralog TAZ; (2) Vgll",
          0.025329134619627457
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56afe6d40a360a5e45000017",
      "exact_answer": [
        [
          "CAGEr",
          0.9998633707797678
        ],
        [
          "CAGEr: precise TSS",
          3.7248690673704745e-05
        ],
        [
          "r",
          2.2858695925298464e-05
        ],
        [
          "CAGEr: precise TSS data retrieval and high-resolution promoterome mining",
          9.775624483690584e-06
        ],
        [
          "CAGE",
          6.994583697905136e-06
        ],
        [
          "CAGEr,",
          1.207143856345024e-06
        ],
        [
          "CAGE)",
          3.876244560831039e-09
        ],
        [
          "FANTOM5",
          2.0900908155820235e-09
        ],
        [
          "Cap analysis of gene expression",
          1.7677852041099412e-09
        ],
        [
          "Cap analysis of gene expression (CAGE)",
          1.3042380042754944e-09
        ],
        [
          "Cap analysis of gene expression (CAGE",
          1.077628193181748e-09
        ],
        [
          "promoterome mining for integrative analyses. Cap analysis of gene expression",
          1.0626543071298134e-09
        ],
        [
          "CAGE toolbox on a common analysis platform.",
          9.18374446715126e-10
        ],
        [
          "r: precise TSS",
          8.515728434592902e-10
        ],
        [
          "high-resolution promoterome mining for integrative analyses. Cap analysis of gene expression",
          8.221007793343847e-10
        ],
        [
          "promoterome mining for integrative analyses. Cap analysis of gene expression (CAGE)",
          7.840059581579978e-10
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56b7083376d8bf8d13000001",
      "exact_answer": [
        [
          "Fusarium oxysporum",
          6.209168729956114
        ],
        [
          "fungi",
          0.4563308038062114
        ],
        [
          "Fusarium oxysporum f. sp. cubense",
          0.16003664745628987
        ],
        [
          "Fusarium oxysporum f.sp. cubense",
          0.0742524036233383
        ],
        [
          "fungus Fusarium oxysporum",
          0.03491848545174558
        ],
        [
          "Fusarium",
          0.008803020503395561
        ],
        [
          "Fusarium oxysporum f. sp. cubense,",
          0.008370297217347332
        ],
        [
          "Fusarium oxysporum f.sp. cubense, a causative agent of Panama disease.",
          0.007301028035290395
        ],
        [
          "Fusarium oxysporum f. sp. cubense (Foc), the causal agent of Fusarium wilt",
          0.005598161103912676
        ],
        [
          "fungus Fusarium oxysporum f. sp. cubense",
          0.00534962807710722
        ],
        [
          "Fusarium oxysporum f. sp. cubense race 4",
          0.0049836151041563895
        ],
        [
          "fungi with independent evolutionary origins.",
          0.004963321988379511
        ],
        [
          "Fusarium oxysporum f. sp. cubense.",
          0.004922436132791172
        ],
        [
          "Fusarium oxysporum f. sp.",
          0.0037642992985295735
        ],
        [
          "Fusarium oxysporum f. sp. cubense race 4 (FOC",
          0.0023571075758865973
        ],
        [
          "Fusarium oxysporum f.sp. cubense,",
          0.0010688081672379122
        ],
        [
          "Fusarium oxysporum f. sp. cubense race 4 (FOC)",
          0.0009973845548629985
        ],
        [
          "fungus",
          0.0007436419774002521
        ],
        [
          "fungus Fusarium oxysporum f. sp. cubense,",
          0.0006949511515879346
        ],
        [
          "Fusarium oxysporum f.sp. cubense, a causative agent of Panama disease",
          0.000600906830021123
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56bc751eac7ad10019000013",
      "exact_answer": [
        [
          "Bazex syndrome",
          3.3824497456333646
        ],
        [
          "Bazex",
          0.6981513421223118
        ],
        [
          "upper aerodigestive tract squamous cell carcinoma",
          0.6487482823434965
        ],
        [
          "Acrokeratosis paraneoplastica Bazex",
          0.37303996710683346
        ],
        [
          "pyriform sinus tumour",
          0.12971946378523763
        ],
        [
          "palmoplantar hyperkeratosis",
          0.12956577910897715
        ],
        [
          "Bazex is a rare, obligate paraneoplasia initially presenting with palmoplantar hyperkeratosis",
          0.1003598924377278
        ],
        [
          "squamous cell carcinoma",
          0.07214787576290346
        ],
        [
          "acrokeratosis neoplastica Bazex?]. Acrokeratosis paraneoplastica Bazex",
          0.06929345442851646
        ],
        [
          "paraneoplastic dermatosis",
          0.055452448924908256
        ],
        [
          "Bazex is a rare, obligate paraneoplasia",
          0.047526972731573185
        ],
        [
          "Acrokeratosis paraneoplastica Bazex is a rare, obligate paraneoplasia",
          0.04474887511298921
        ],
        [
          "Bazex is a rare but important paraneoplastic dermatosis",
          0.03436945399664235
        ],
        [
          "Bazex (APB",
          0.028914583908412204
        ],
        [
          "Acrokeratosis paraneoplastica of Bazex is a rare but important paraneoplastic dermatosis",
          0.025178050240055507
        ],
        [
          "Acrokeratosis paraneoplastica Bazex syndrome",
          0.02241232941104031
        ],
        [
          "palmoplantar hyperkeratosis.",
          0.014232731377054025
        ],
        [
          "paraneoplasia initially presenting with palmoplantar hyperkeratosis",
          0.011095519468663662
        ],
        [
          "Bazex is a rare, obligate paraneoplasia initially presenting with palmoplantar hyperkeratosis.",
          0.01102448038300915
        ],
        [
          "acrokeratosis neoplastica Bazex",
          0.010701983484347878
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c5fd325795f9a73e000005",
      "exact_answer": [
        [
          "SMN1",
          3.6763489807180267
        ],
        [
          "SMN",
          1.5236452113769925
        ],
        [
          "Autosomal dominant",
          0.9790367096559609
        ],
        [
          "VRK1",
          0.9736464464196211
        ],
        [
          "proximal spinal muscular atrophy",
          0.8541496868047953
        ],
        [
          "recessive",
          0.829420401744367
        ],
        [
          "recessive autosomal",
          0.40408192526240416
        ],
        [
          "mutations in a gene encoding a novel protein, SMN",
          0.27586972997079096
        ],
        [
          "autosomal",
          0.2600132527264093
        ],
        [
          "SMA is the commonest form and is due to mutations in a gene encoding a novel protein, SMN",
          0.14044404493994125
        ],
        [
          "recessive disorder characterized by the loss of lower motor neurons in the spinal cord.",
          0.1126302557380753
        ],
        [
          "SMN1)",
          0.10245390788268248
        ],
        [
          "proximal",
          0.08204929075312108
        ],
        [
          "SMN1) leading to a reduction of the SMN protein amount.",
          0.06224632148402467
        ],
        [
          "SMN,",
          0.03286030869114971
        ],
        [
          "SMN1 genotype.",
          0.027434621047006637
        ],
        [
          "autosomal recessive disorders characterized by degeneration of lower motor neurons.",
          0.027088458957660426
        ],
        [
          "SMN1 gene. Six additional patients had anterior horn cell disease but were negative for the SMN1",
          0.02576031167052234
        ],
        [
          "recessive disorder characterized by the loss of lower motor neurons in the spinal cord",
          0.0243223131585873
        ],
        [
          "SMN1) leading to a reduction of the SMN protein amount. The identification of SMN",
          0.019494208631926753
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56cb9b065795f9a73e000032",
      "exact_answer": [
        [
          "aurora A",
          0.5415228168275128
        ],
        [
          "aurora A kinase,",
          0.22199617565443572
        ],
        [
          "aurora A kinase",
          0.13191613969171948
        ],
        [
          "Aurora A kinase activity in vitro. In human cells however, only Tripolin A acted as an Aurora A",
          0.03153019628443712
        ],
        [
          "Tripolin A, a novel small-molecule inhibitor of aurora A",
          0.02747984978980007
        ],
        [
          "Tripolin A, a novel small-molecule inhibitor of aurora A kinase,",
          0.012634557857942248
        ],
        [
          "Aurora A phosphorylation. Tripolin A is predicted to bind Aurora A",
          0.008046148089435292
        ],
        [
          "Tripolin A, a novel small-molecule inhibitor of aurora A kinase",
          0.007376883355072792
        ],
        [
          "Tripolin A and Tripolin B, inhibited Aurora A",
          0.005688108469662397
        ],
        [
          "pAurora A",
          0.002688935584004069
        ],
        [
          "Tripolin A,",
          0.0017847079170268004
        ],
        [
          "Tripolin A acted as an Aurora A",
          0.001181174161821741
        ],
        [
          "Aurora A inhibition by RNAi",
          0.0010513363653525617
        ],
        [
          "Tripolin A",
          0.0010173493950307905
        ],
        [
          "Tripolin A, a non-ATP competitive inhibitor. Tripolin A reduced the localization of pAurora A",
          0.0005747391778751993
        ],
        [
          "ATP competitive inhibitor. Tripolin A reduced the localization of pAurora A",
          0.00042179778963683933
        ],
        [
          "Tripolin A reduced the localization of pAurora A",
          0.0003811574998483215
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56caea805795f9a73e00002c",
      "exact_answer": [
        [
          "SLC38A9",
          1.871350073146291
        ],
        [
          "SLC38A9 expression impaired amino-acid-induced mTORC1 activation. Thus SLC38A9",
          0.07710220981844663
        ],
        [
          "SLC38A9 as an integral part of the Ragulator-RAG GTPases machinery. Gain of SLC38A9",
          0.024684333693367703
        ],
        [
          "mTORC1 activation. Thus SLC38A9",
          0.013017382227652516
        ],
        [
          "SLC38A9 as a novel component of the Rag-Ragulator complex. SLC38A9",
          0.005686369067576751
        ],
        [
          "SLC38A9 as an integral part of the Ragulator-RAG GTPases machinery.",
          0.002840773887099193
        ],
        [
          "SLC38A9 function rendered cells resistant to amino acid withdrawal, whereas loss of SLC38A9",
          0.0018918830189814213
        ],
        [
          "mTORC1",
          0.0013374614502285845
        ],
        [
          "SLC38A9 expression impaired amino-acid-induced mTORC1",
          0.0004974825523657326
        ],
        [
          "SLC38A",
          0.00033012038887520855
        ],
        [
          "SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1",
          0.00016670451765496376
        ],
        [
          "mTORC1)",
          0.0001432859852200701
        ],
        [
          "rapamycin complex 1 (mTORC1",
          0.00010027680849143255
        ],
        [
          "SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1.",
          9.873893823693499e-05
        ],
        [
          "(mTORC1",
          6.600068039460392e-05
        ],
        [
          "Rag-Ragulator complex. SLC38A9",
          4.994547196712852e-05
        ],
        [
          "mTORC1.",
          4.9149195486462805e-05
        ],
        [
          "mTORC1 is activated at the surface of lysosomes by the RAG GTPases",
          3.5980012380647015e-05
        ],
        [
          "SLC38A9 expression impaired amino-acid-induced mTORC1 activation. Thus SLC38A",
          2.9019002910239643e-05
        ],
        [
          "rapamycin complex 1",
          2.4272745903349033e-05
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c865d25795f9a73e000016",
      "exact_answer": [
        [
          "GKT136901",
          1.9996897163150784
        ],
        [
          "GKT137831",
          0.9995740672801714
        ],
        [
          "GKT",
          0.00019192204076653267
        ],
        [
          "GKT136901,",
          0.0001449209277272003
        ],
        [
          "GKT13",
          7.128133384467982e-05
        ],
        [
          "GK",
          6.571966477826747e-05
        ],
        [
          "Nox1/Nox4 inhibitor GKT137831",
          5.1745404756906445e-05
        ],
        [
          "GKT137",
          4.0295470645680705e-05
        ],
        [
          "GKT1378",
          3.9836802271127755e-05
        ],
        [
          "GKT136",
          3.4879884790987577e-05
        ],
        [
          "GKT136901, a specific inhibitor of Nox1- and Nox4-containing NADPH",
          1.8742370054653435e-05
        ],
        [
          "Nox4 inhibitor GKT137831",
          1.3698087734422348e-05
        ],
        [
          "GKT13690",
          1.3039491189819048e-05
        ],
        [
          "GKT136901 (Nox1/4 inhibitor)",
          1.1346276031526755e-05
        ],
        [
          "GKT137831. GKT137831",
          1.0278004602499878e-05
        ],
        [
          "G",
          9.850409927116722e-06
        ],
        [
          "1",
          5.20404922153224e-06
        ],
        [
          "GKT136901, a specific inhibitor of Nox1",
          3.8004201574201764e-06
        ],
        [
          "GKT137831.",
          3.613990800791788e-06
        ],
        [
          "GKT136901 (Nox1",
          1.6357382528765687e-06
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56cae60f5795f9a73e00002b",
      "exact_answer": [
        [
          "Ataxin-2",
          1.2019421384584683
        ],
        [
          "ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Instability of CAG",
          0.16347953773879137
        ],
        [
          "ataxin-2 are not necessary for SCA2",
          0.09819159261091348
        ],
        [
          "SCA2 pathogenesis in mouse or human. Instability of CAG",
          0.09623582643846902
        ],
        [
          "SCA2",
          0.05780284339291664
        ],
        [
          "ataxin-1[Q80] transgenic lines, ataxin-2",
          0.05505835173153287
        ],
        [
          "CAG",
          0.054885224263102245
        ],
        [
          "polyglutamine",
          0.04665963258610949
        ],
        [
          "ataxin",
          0.03538878566461602
        ],
        [
          "SCA2)",
          0.026481211251454678
        ],
        [
          "(SCA2",
          0.02447797059084639
        ],
        [
          "ataxin-2[Q58",
          0.023740923871049206
        ],
        [
          "SCA2) pathogenesis using cultured cells, human brains and transgenic mouse lines. In SCA2",
          0.02344717938697128
        ],
        [
          "ataxin-2[Q58]",
          0.016352883554604954
        ],
        [
          "ataxin-2 with Q58",
          0.014767665256395765
        ],
        [
          "spinocerebellar ataxia type 2 (SCA2",
          0.014344059682661359
        ],
        [
          "(SCA2)",
          0.01411487957539469
        ],
        [
          "(SCA2) pathogenesis using cultured cells, human brains and transgenic mouse lines. In SCA2",
          0.01249769545234062
        ],
        [
          "ataxin-1",
          0.009787194614806708
        ],
        [
          "ataxin-1[Q80] transgenic lines, ataxin",
          0.009582845535236183
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c073fcef6e394741000020",
      "exact_answer": [
        [
          "Spermidine protects",
          0.3967943303364863
        ],
        [
          "Spermidine protects against \u03b1-synuclein neurotoxicity.",
          0.21352308514061824
        ],
        [
          "Spermidine",
          0.11888094866817675
        ],
        [
          "Spermidine protects against",
          0.1070948463146263
        ],
        [
          "protects",
          0.03303699365250415
        ],
        [
          "Spermidine protects against \u03b1-synuclein neurotoxicity",
          0.030859548005292656
        ],
        [
          "Spermidine protects against \u03b1-synuclein",
          0.0210396374494592
        ],
        [
          "protects against \u03b1-synuclein neurotoxicity.",
          0.01777787702377626
        ],
        [
          "spermidine, which declines continuously during aging",
          0.011585315176739552
        ],
        [
          "protects against",
          0.008916689295716177
        ],
        [
          "spermidine,",
          0.008087255708749902
        ],
        [
          "spermidine, which declines continuously during aging in various species,",
          0.006080295721008127
        ],
        [
          "Alleviation of PD-related neurodegeneration",
          0.005222889329205354
        ],
        [
          "Alleviation of PD-related neurodegeneration by spermidine was accompanied by induction of autophagy",
          0.004621814276539293
        ],
        [
          "autophagy",
          0.004448036371936817
        ],
        [
          "spermidine inhibited loss of climbing activity and early organismal death",
          0.00330969447823624
        ],
        [
          ".",
          0.003049177369616305
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c341acfedd0b786b000001",
      "exact_answer": [
        [
          "structural arrangement",
          0.7860915105555522
        ],
        [
          "hypersensitivity",
          0.7217885658262602
        ],
        [
          "diadduct forming",
          0.5172018612131917
        ],
        [
          "rate of relaxation of superhelical turns",
          0.4024372963337254
        ],
        [
          "(omega-diethyl aminopropyloxy)psoralen hydrochloride",
          0.21723478268252058
        ],
        [
          "The structural arrangement",
          0.18044163110068076
        ],
        [
          "diadduct forming derivatives",
          0.15163500820623393
        ],
        [
          "relaxation of superhelical turns",
          0.15046701560935158
        ],
        [
          "8-(omega-diethyl aminopropyloxy)psoralen hydrochloride",
          0.13394874878224386
        ],
        [
          "hypersensitivity of (GT)n B-Z junctions",
          0.12726254555317892
        ],
        [
          "psoralen hydrochloride",
          0.09908824504336428
        ],
        [
          "monoadduct and diadduct forming",
          0.09899193945948302
        ],
        [
          "psoralen hydrochloride (I) and its 5-isomer (II),",
          0.08855228063856795
        ],
        [
          "rate of relaxation",
          0.07692093485373326
        ],
        [
          "(omega-diethyl aminopropyloxy)psoralen hydrochloride (I)",
          0.0692154755441243
        ],
        [
          "diadduct",
          0.04861194022434987
        ],
        [
          "8-(omega-diethyl aminopropyloxy)psoralen hydrochloride (I)",
          0.042678829932373666
        ],
        [
          "intercalate into the polynucleotide double helix.",
          0.0403988392715856
        ],
        [
          "The rate of relaxation of superhelical turns",
          0.039706418512901395
        ],
        [
          "(omega-diethyl aminopropyloxy)",
          0.038886755744903884
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56af9f130a360a5e45000015",
      "exact_answer": [
        [
          "membrane",
          0.9534108819594985
        ],
        [
          "zebrafish retina",
          0.8233653079237381
        ],
        [
          ".",
          0.6082719419585783
        ],
        [
          "Cx43",
          0.5814465200066135
        ],
        [
          "extracellular space",
          0.5371526982405078
        ],
        [
          "the outer retina",
          0.51303964320317
        ],
        [
          "Panx1",
          0.49163384500032076
        ],
        [
          "outer retina",
          0.4725702663037518
        ],
        [
          "Panx",
          0.4646189588545236
        ],
        [
          "Pannexin1 (Panx1) is fairly ubiquitous",
          0.38147985585926886
        ],
        [
          "ubiquitous",
          0.3668932328759972
        ],
        [
          "the extracellular space",
          0.3385504418147187
        ],
        [
          "extracellular nucleotides via pannexin1 channels.",
          0.28278110603138557
        ],
        [
          "Pannexin1 (Panx1",
          0.21337992329048405
        ],
        [
          "Panx1).",
          0.1719970964452049
        ],
        [
          "Pannexin1",
          0.1579137830683018
        ],
        [
          "Panx1)",
          0.147812951510797
        ],
        [
          "the zebrafish retina",
          0.13429714418028638
        ],
        [
          "pannexin (Panx",
          0.12490613705240533
        ],
        [
          "Panx) channels. Panx1",
          0.11702823973838482
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56bc932aac7ad1001900001c",
      "exact_answer": [
        [
          "CD38",
          4.575692790827719
        ],
        [
          "IgG1\u03ba monoclonal antibody that recognizes CD38",
          0.276118023206487
        ],
        [
          "CD38 on myeloma cells.",
          0.026564321525534604
        ],
        [
          "IgG1\u03ba",
          0.01544087527959413
        ],
        [
          "CD38, has been of great interest in the treatment of CD38",
          0.012102857168354072
        ],
        [
          "CD38+ or CD38- HL60 cells was assessed by flow cytometry. To remove cell surface CD38",
          0.01207583433047616
        ],
        [
          "IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
          0.011737589318400281
        ],
        [
          "CD38 epitope with broad-spectrum killing activity.",
          0.01155794567252695
        ],
        [
          "CD38, cells were incubated with dithiothreitol (DTT) or trypsin. Soluble CD38",
          0.010778665899111693
        ],
        [
          "CD38,",
          0.007119459096411318
        ],
        [
          "monoclonal antibody against unique CD38",
          0.004372476284023542
        ],
        [
          "\u03ba monoclonal antibody that recognizes CD38",
          0.004146957090761882
        ],
        [
          "CD38.",
          0.003563223543120546
        ],
        [
          "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
          0.0035134286308415377
        ],
        [
          "CD38+ or CD38",
          0.0031879707883149624
        ],
        [
          "IgG1",
          0.003133581977020248
        ],
        [
          "DARA binding to CD38",
          0.0021962779241302536
        ],
        [
          "CD38- HL60 cells was assessed by flow cytometry. To remove cell surface CD38",
          0.0018790203327555767
        ],
        [
          "CD38 epitope",
          0.0015748786154577146
        ],
        [
          "daratumumab which targets CD38",
          0.0012541233876250863
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56b330bb39c782df06000001",
      "exact_answer": [
        [
          "Sushi.R",
          0.9955129409157172
        ],
        [
          "Sushi",
          0.0022267289941815312
        ],
        [
          "Bioconductor",
          0.000919281645432628
        ],
        [
          "Sushi.R: flexible",
          0.0007453689896387808
        ],
        [
          "Sushi.",
          0.0002470058429220045
        ],
        [
          "Sushi.R,",
          9.301896135488355e-05
        ],
        [
          "Bioconductor (http://bioconductor.org/packages/release/bioc/html/Sushi",
          8.460538176717841e-05
        ],
        [
          "Bioconductor (http://bioconductor.org/packages/release/bioc/html/Sushi.html).",
          7.766196867062811e-05
        ],
        [
          "Bioconductor (http://bioconductor.org/packages/release/bioc/html/Sushi.html",
          5.6679736018669356e-05
        ],
        [
          "Sushi) and Bioconductor",
          1.099561527906601e-05
        ],
        [
          "R",
          9.683695738168371e-06
        ],
        [
          "Sushi.html).",
          4.760292487609406e-06
        ],
        [
          "GitHub (https://github.com/dphansti/Sushi) and Bioconductor",
          3.869398195045604e-06
        ],
        [
          "Sushi.html",
          3.4741859649947212e-06
        ],
        [
          "Sushi) and Bioconductor (http://bioconductor.org/packages/release/bioc/html/Sushi",
          1.0119730259735493e-06
        ],
        [
          "bedGraph and Browser Extensible Data Paired-End (BEDPE). Sushi.R",
          8.913257324134068e-07
        ],
        [
          "Sushi) and Bioconductor (http://bioconductor.org/packages/release/bioc/html/Sushi.html",
          6.779517185802268e-07
        ],
        [
          "BEDPE). Sushi.R",
          5.497359676476092e-07
        ],
        [
          "Sushi)",
          4.0276704141991527e-07
        ],
        [
          "Browser Extensible Data Paired-End (BEDPE). Sushi.R",
          3.90623145238798e-07
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c86aa95795f9a73e000018",
      "exact_answer": [
        [
          "PGI(2)",
          0.6416486914352734
        ],
        [
          "PGI",
          0.45752498607228764
        ],
        [
          "I2",
          0.29376714983976915
        ],
        [
          "Prostaglandin I2",
          0.2346587092114689
        ],
        [
          "PGI(2",
          0.1909818858685012
        ],
        [
          "Prostaglandin I2 (PGI2",
          0.17133645614740212
        ],
        [
          "PGI2",
          0.15885470234777244
        ],
        [
          "Prostaglandin I(2)",
          0.13423804743180076
        ],
        [
          "PGI(2) analogues (iloprost,",
          0.0728548460860253
        ],
        [
          "(iloprost,",
          0.06724375051297284
        ],
        [
          "Prostaglandin I(2) (PGI(2))",
          0.062207665711117396
        ],
        [
          "Prostaglandin I2 (PGI2)",
          0.04081882290123848
        ],
        [
          "PGI2)",
          0.03784519715164538
        ],
        [
          "PGI(2) analogues (iloprost, treprostinil and beraprost)",
          0.037274292156182824
        ],
        [
          "Prostaglandin I(2",
          0.03539850946867675
        ],
        [
          "(iloprost, treprostinil and beraprost)",
          0.031211852194082193
        ],
        [
          "(iloprost, treprostinil and beraprost) significantly increased IL-17A",
          0.026495376418495323
        ],
        [
          "PGI(2) analogues (iloprost, treprostinil",
          0.025816943904319278
        ],
        [
          "(iloprost, treprostinil and beraprost) significantly increased IL-17A and IL-22",
          0.0236123857048341
        ],
        [
          "PGI(2) analogs iloprost",
          0.02291015282024602
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c1f01aef6e394741000043",
      "exact_answer": [
        [
          "PD-1",
          2.9184940512800286
        ],
        [
          "programmed cell death-1",
          0.5725564469937822
        ],
        [
          "programmed death 1 immune checkpoint",
          0.349808835372412
        ],
        [
          "programmed death 1",
          0.34017348124907015
        ],
        [
          "anti programmed cell death-1",
          0.2776466584689167
        ],
        [
          "programmed death",
          0.14096538520812857
        ],
        [
          "programmed death 1 immune checkpoint inhibitor",
          0.05004190747654394
        ],
        [
          "programmed death 1 immune checkpoint inhibitor,",
          0.04403613336703851
        ],
        [
          "CTLA-4) and pembrolizumab (PD-1",
          0.04064015764661067
        ],
        [
          "Ipilimumab (CTLA-4) and pembrolizumab (PD-1",
          0.0393402637660333
        ],
        [
          "programmed cell death-1 (PD-1",
          0.0356393515769059
        ],
        [
          "PD-1)",
          0.02015939812301957
        ],
        [
          "anti programmed cell death-1 (PD-1",
          0.01728239534683695
        ],
        [
          "(PD-1",
          0.014782181119716267
        ],
        [
          "anti-programmed death 1 immune checkpoint",
          0.012222757550417553
        ],
        [
          "anti-programmed death 1",
          0.01188608624468383
        ],
        [
          "pembrolizumab (PD-1",
          0.010185120325134984
        ],
        [
          "anti-PD-1",
          0.009986093387117062
        ],
        [
          "programmed death protein 1 (PD-1) pathway, both anti-PD-1",
          0.008898595148981425
        ],
        [
          "pembrolizumab, an anti-programmed death 1 immune checkpoint",
          0.008028961254860453
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56bc7d71ac7ad10019000018",
      "exact_answer": [
        [
          "MDR-Tb",
          1.99741081099363
        ],
        [
          "MDR-TB.",
          0.34872217846719966
        ],
        [
          "Tb",
          0.1834207791655775
        ],
        [
          "MDR-TB patients. In addition, decreased mortality was observed in MDR-TB",
          0.09040332565949075
        ],
        [
          "MDR-TB in combination with other anti-TB",
          0.0435707930965941
        ],
        [
          "MDR-Tb when other alternatives fail.",
          0.042382309352937214
        ],
        [
          "multidrug-resistant tuberculosis (MDR-TB",
          0.030441726810692335
        ],
        [
          "MDR-Tb when other alternatives fail. The goal of elimination of Tb",
          0.030002347687009955
        ],
        [
          "tuberculosis (TB",
          0.02744997374477497
        ],
        [
          "TB. Delamanid was generally well tolerated in patients with MDR-TB",
          0.021847316666245113
        ],
        [
          "MDR-TB patients.",
          0.017458022875834513
        ],
        [
          "MDR-TB,",
          0.015115488880037747
        ],
        [
          "MDR-TB)",
          0.012761257983526734
        ],
        [
          "tuberculosis (MDR-TB",
          0.012449079395282822
        ],
        [
          ".",
          0.012113548522445554
        ],
        [
          "anti-Tb",
          0.011413791222689339
        ],
        [
          "MDR-TB in combination with other anti-TB drugs.",
          0.009833582947134281
        ],
        [
          "tuberculosis",
          0.008746509355802864
        ],
        [
          "pulmonary MDR-TB",
          0.007917410387671344
        ],
        [
          "TB)",
          0.0069547731910115955
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56bc9268ac7ad1001900001b",
      "exact_answer": [
        [
          "IL-17",
          1.9948212118153643
        ],
        [
          "interleukin-17",
          0.7856441811755255
        ],
        [
          "IL17A",
          0.7333536896980529
        ],
        [
          "interleukin-17 receptor A",
          0.19694866249531245
        ],
        [
          "IL17A inhibitors secukinumab and ixekizumab, the IL17A",
          0.1088161571129337
        ],
        [
          "IL17A receptor inhibitor, brodalumab, and the IL23",
          0.10846002373148625
        ],
        [
          "IL17A receptor inhibitor, brodalumab,",
          0.014093948321386236
        ],
        [
          "IL17A receptor",
          0.010200225833709544
        ],
        [
          "interleukin",
          0.006952450272213173
        ],
        [
          "IL12/IL23 inhibitor, ustekinumab, the IL17A",
          0.0044889471385860455
        ],
        [
          "IL23 inhibitor, ustekinumab, the IL17A",
          0.0042431022127861085
        ],
        [
          "IL23",
          0.0037503997029099934
        ],
        [
          "IL-17 antagonists, secukinumab, brodalumab and ixekizumab; the IL-23",
          0.0037162777692303557
        ],
        [
          "anti-interleukin-17",
          0.0032769062145107017
        ],
        [
          "IL12/IL23",
          0.0031999651901637822
        ],
        [
          "IL17A receptor inhibitor, brodalumab, and the IL23 inhibitors guselkumab and tildrakizumab,",
          0.002350951183996891
        ],
        [
          "IL17A inhibitors secukinumab and ixekizumab, the IL17A receptor inhibitor, brodalumab,",
          0.0020912818963425266
        ],
        [
          "IL12",
          0.0020028234847508683
        ],
        [
          "interleukin-17 receptor A monoclonal antibody brodalumab",
          0.001930026960566362
        ],
        [
          "interleukin-17 receptor",
          0.0016609427151761309
        ]
      ],
      "ideal_answer": "Dummy"
    },
    {
      "type": "factoid",
      "id": "56c3320a50c68dd416000008",
      "exact_answer": [
        [
          "one tenth",
          0.9986902735231855
        ],
        [
          "1 in 2000 live births",
          0.9617010093103867
        ],
        [
          "1:30,000",
          0.8359955784376812
        ],
        [
          ".",
          0.8303055093661316
        ],
        [
          "1:3300",
          0.7291016534959399
        ],
        [
          "1:25,000 newborn",
          0.42813267610832423
        ],
        [
          "Cystic fibrosis is the most common, severe, inherited disease in the Caucasian population.",
          0.42380464520714706
        ],
        [
          "4 times more to 40 times less common",
          0.37531980145707283
        ],
        [
          "Cystic fibrosis is the most common, severe, inherited disease in the Caucasian population",
          0.22933382815022607
        ],
        [
          "delta F508",
          0.22776809901975004
        ],
        [
          "4 times more to 40 times less common than the generally accepted figure of 1:2000.",
          0.18581731860482364
        ],
        [
          "4 times more to 40 times less common than the generally accepted figure of 1:2000",
          0.17812242245743815
        ],
        [
          "Cystic fibrosis is the most common",
          0.1757763643396952
        ],
        [
          "CF is 1:3300",
          0.10607507799756821
        ],
        [
          "delta F508 mutation",
          0.10089962087984074
        ],
        [
          "1:10,000 to 1:40,000. The clinical features are similar to that reported in Caucasian population.",
          0.09034761100395723
        ],
        [
          "1:30,000.",
          0.08940203393043326
        ],
        [
          "1:25,000 newborn, is one of the lowest",
          0.08546297768694928
        ],
        [
          "lower than the reported frequency among the Western Caucasian population",
          0.08214741834360113
        ],
        [
          "1:25,000 newborn, is one of the lowest in Caucasian populations.",
          0.07429242682736063
        ]
      ],
      "ideal_answer": "Dummy"
    }
  ]
}